Medication of hydroxychloroquine, remdesivir and convalescent plasma during the COVID-19 pandemic in Germany : an ethical analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: International Journal of Environmental Research and Public Health ; 18 (2021), 11. - Art.-Nr. 5685. - eISSN 1660-4601
- Keyword
-
COVID-19
Arzneimittel
Medizinethik
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2021
- Creator
- DOI
-
10.18725/OPARU-39675
- URN
-
urn:nbn:de:bsz:289-oparu-39751-3
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Voit, Katja
- Timmermann, Cristian
- Steger, Florian
- Universität Ulm
Time of origin
- 2021
Other Objects (12)
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
The Convalescent
The convalescent
Solubility measurement and modeling of hydroxychloroquine sulfate (antimalarial medication) in supercritical carbon dioxide
The illustrious convalescent
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
"The convalescent" in France
The Liverpool convalescent institution.
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
The Convalescent
The convalescent
Solubility measurement and modeling of hydroxychloroquine sulfate (antimalarial medication) in supercritical carbon dioxide
The illustrious convalescent
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
"The convalescent" in France
The Liverpool convalescent institution.
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
The Convalescent
The convalescent
Solubility measurement and modeling of hydroxychloroquine sulfate (antimalarial medication) in supercritical carbon dioxide
The illustrious convalescent
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
"The convalescent" in France
The Liverpool convalescent institution.
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir